Association of adiponectin and socioeconomic status in African American men and women: the Jackson heart study by Sharon K. Davis et al.
RESEARCH ARTICLE Open Access
Association of adiponectin and
socioeconomic status in African American
men and women: the Jackson heart study
Sharon K. Davis1*, Ruihua Xu1, Pia Riestra1, Samson Y. Gebreab1, Rumana J. Khan1, Amadou Gaye1,
DeMarc Hickson2, Mario Sims2 and Aurelian Bidulescu3
Abstract
Background: Recent emphasis has been placed on elucidating the biologic mechanism linking socioeconomic
status (SES) to cardiovascular disease (CVD). Positive associations of inflammatory biomarkers provide evidence
suggestive of a biologic pathway by which SES may predispose to CVD. African Americans have disproportionately
lower SES and have a higher prevalence of CVD risk factors compared to most ethnic/racial groups. Adiponectin
(an anti-inflammatory marker) is also lower. The objective of this study was to assess the association of adiponectin
with SES among African American men and women using the Jackson Heart Study.
Methods: Study sample included 4340 participants. Linear regression was performed separately by SES and stratified
by sex. Annual household income and level of education was used as proxies for SES. Crude, age, health behavior and
health status adjusted models were analyzed. The main outcome was log-transformed adiponectin.
Results: Men in the lowest income group had significantly higher adiponectin than those in the highest income
group in the fully adjusted model (ß/standard error [se], p value = .16/.08, p = .0008. Men with < high school level
of education had significantly higher adiponectin in the crude and age adjusted models than those with ≥ college
degree (.25/.05, p < .0001; .14/.05/ p = .005, respectively). Women with some college or vocational training in the
crude and age adjusted models had lower adiponectin compared to women with ≥ college degree (−.09/.03,
p = .004; −.06/.03, p = .04, respectively).
Conclusion: Findings suggest a potential inverse biologic pathway between annual household income and
adiponectin among African American men. There was no such finding among women. Findings suggest interventions
should be targeted for higher SES African American men to improve adiponectin levels.
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Background
Research has consistently demonstrated an inverse asso-
ciation with socioeconomic status (SES) and cardiovas-
cular disease (CVD) related mortality, morbidity and
risk factors [1–4]. More recent emphasis has been
placed on elucidating the biologic mechanism linking
SES to CVD [5, 6]. Investigations show a significant in-
verse association between pro and anti-inflammatory
biomarkers with SES which provide evidence suggestive
of a biologic pathway by which SES may predispose to
CVD [5–10]. These investigations suggest greater in-
flammation burden in those of lower SES. However, few
studies have investigated the socioeconomic patterning
of inflammatory biomarkers among African Americans.
Those that include African Americans report adverse
biomarker concentrations when compared to other ra-
cial/ethnic groups [9]. Research also shows lower SES
African Americans have a higher prevalence of CVD risk
factors [11]. Adiponectin is an anti-inflammatory bio-
marker that has increasingly been proposed as a risk fac-
tor for CVD related outcomes [12]. Adiponectin is a
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type of adipokine that is produced and secreted predomin-
antly by adipocytes and lower levels has deleterious effects
on the metabolic and vascular system which is inversely
associated with type 2 diabetes and hypertension [13, 14].
Research demonstrates that African Americans have lower
levels of adiponectin and a higher prevalence of obesity,
hypertension and type 2 diabetes compared to other ra-
cial/ethnic groups in the United States [15, 16]. Lower
SES is also disproportionately prevalent among African
Americans [16]. We are aware of only three studies that
compare adiponectin by SES [10, 17, 18]. To date, re-
search has not been conducted in the United States that
compares the association between adiponectin and SES
among African American men and women or any
other racial/ethnic group. Investigating the association
between adiponectin and SES may provide important
insights into the biological pathways linking SES with
CVD and related risk factors in the higher risk popu-
lation of African Americans. The objective of our
study is to test the hypothesis that level of adiponec-
tin may differ by SES among African American men
and women and such association may be mediated by
health status and health behavior.
Methods
Data from the Jackson Heart Study (JHS) was used
which is a single-site, prospective cohort of risk factors
and causes of heart disease in adult African Americans.
A probability sample of 5301 African Americans, aged
21–95, residing in three contiguous counties surround-
ing Jackson, Mississippi was recruited and examined at
baseline from 2000 to 2004 by certified technicians ac-
cording to standardized protocols [19, 20]. The present
study includes cross-sectional data on 4340 participants
who had complete data on all variables of interest. Those
participants with missing values in the variables of inter-
est were excluded. Baseline examination included blood
pressure, anthropometry, survey of medical history, car-
diovascular risk factors and collection of blood and urine
for biological variables. Written consent was obtained
from each participant before the collection of data. The
study protocol was approved by the Institutional Review
Boards of the National Institutes of Health and the
participating JHS institutions-including the University
of Mississippi Medical Center, Tougaloo College, and
Jackson State University.
Outcome variable
Adiponectin measurement was derived from venous
blood samples drawn from each participant at baseline
after more than 8 h of fasting. Vials of serum were
stored at the JHS central repository in Minneapolis, MN,
at −80 °C until assayed. Adiponectin concentration was
measured in 2008–2012 as total plasma adiponectin by
an ELISA system (R&D Systems; Minneapolis, MN. The
inter-assay coefficient of variation was 8.8 %. No bio-
logical degrading has been described using stored speci-
mens, indicating a high validity for measurement [21].
The distribution of plasma adiponectin values were posi-
tively skewed and were subsequently log-transformed for
statistical analyses.
Primary predictor variable
We used two measures of SES—self-reported pre-tax
annual household income and educational level. Annual
household income was divided into three categories
(≤ $19,000, $20,000–$49,000, ≥ $50,000) and educational
level was divided into four categories (<high school, high
school or graduate equivalency diploma (GED), some col-
lege or vocational school, ≥ college graduate).
Covariates
All covariates were collected at baseline and were
chosen because they are associated with adiposity and
hypertension related adiponectin [12]. Age was derived
from date-of-birth. We further categorize covariates into
health behavior and health status as mediator variables
to determine if they would affect outcome. Health be-
havior variables include smoking status, physical activity,
alcohol consumption status, and overweight based on
body mass index (BMI) [16]. Smoking status was defined
as current smokers and non-smokers. Physical activity
was assessed with a physical activity survey instrument
comprised of 4 domains (active living, work, home and
garden, sport and exercise indexes). A total score was
the sum of these domains with a maximum of 24 and a
higher score indicates a higher level of physical activity.
Alcohol consumption status was defined as “yes” if par-
ticipant reported ever consuming alcohol and “no” for
those reporting never consuming alcohol. Overweight
was defined as BMI ≥25. Body mass index was derived
from standing height and weight measured in light-
weight clothing without shoes or constricting garments
and calculated as weight in kilograms divided by height
in meters squared (kg/m2). Cardiovascular disease health
status variables include hypertension, type 2 diabetes,
low-density lipoprotein (LDL), high-density lipoprotein
(HDL), triglyceride, homoeostasis model assessment-
insulin resistance (HOMA-IR), and C-reactive protein
(CRP). Hypertension was based on a systolic blood pressure
of ≥140 mmHg, diastolic blood pressure of ≥90 mmHg, or
self-reported medication use for elevated blood pres-
sure [14]. Blood pressure was measured using stand-
ard protocols with participant sitting quietly for 5 min
measured at 1-min intervals. The average of two sitting
blood pressure was used in the analysis. Type 2 diabetes
was defined as fasting plasma glucose ≥126 mg/dL or self-
reported use of insulin or oral hypoglycemic medications
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[13]. Fasting insulin, LDL, HDL and triglyceride were
assessed using standard laboratory techniques. Insulin re-
sistance status was estimated with HOMA-IR [22]. CRP
was measured using immunoturbidimetric CRP-Latex
assay from Kamiya Biomedical Company following manu-
facturer’s high-sensitivity protocol [23]. The inter-assay
coefficients of variation on control samples repeated in
each assay were 4.5 and 4.4 % at CRP concentrations of
0.45 and 1.56 mg/dL, respectively.
Statistical analyses
All analyses were sex stratified because of the differential
levels of adiponectin between men and women [24]. De-
scriptive analyses of the characteristics of men and women
were performed using two sample t-test for continuous
variables and chi-square for categorical variables. Charac-
teristics of men and women stratified by annual household
income and level of education were performed with one-
way ANOVA for continuous variables and chi-square for
categorical variables. Differential age adjusted mean levels
of adiponectin for men and women by the three categories
of income and four categories of education were graphed
for descriptive purposes via one-way ANOVA. Adiponec-
tin was based on sample mean.
Multiple linear regression analysis was utilized to test
the association separately between two SES groups (i.e.
annual household income, educational level) and log-
transformed adiponectin with crude, age, health behavior
and health status adjusted variables; ≥ $50,000 and ≥ col-
lege graduate were entered as referents for annual
household income and level of education, respectively.
Four separate models per SES group were utilized to test
the effects on log-transformed adiponectin in a stepwise
fashion. Model 1 was crude and included annual house-
hold income and educational level, while model 2 added
age entered as a continuous variable. Model 3 added
health behavior variables (BMI ≥25, smoking status, al-
cohol consumption status, physical activity score). Body
mass index ≥25, smoking status, and alcohol consump-
tion were entered as binary variables; physical activity
was continuous. The fully adjusted model added health
status variables (triglycerides, HDL, LDL, HOMA-IR,
type 2 diabetes, hypertension and CRP). Triglycerides,
HDL, LDL, HOMA-IR and CRP were entered as continu-
ous variables; hypertension and type 2 diabetes were en-
tered as binary variables. Tests of linear trends were also
conducted to examine the association of SES sub-groups
with levels of log-transformed adiponectin which were
exponentiated (i.e. geometric means) after model adjust-
ments based on general linear model. This was done to as-
sess change in the magnitude of difference in adiponectin
level between the highest and lowest SES sub-groups and
to assess threshold effects between levels after adjustments
as a measure of SES disparity and adiponectin level. A two-
tailed level of significance was established as p ≤ .05. Ana-
lyses were conducted using SAS version 9.3 [25].
Results
The sex-stratified characteristics of the study population
are presented in Table 1. Women were significantly older
than men (55 years of age versus 54, p = .002). A higher
proportion of men had a higher household income
of ≥ $50,000 compared to women (46 % versus 28 %,
p < .0001). A higher proportion men were current
smokers (17.7 % versus 11 %), consumed alcohol
(60 % versus 40 %) and had a higher mean physical
activity score (8.7 versus 8.2) when compared to women
(p < .0001, respectively). Women on the other hand, had
significantly higher mean BMI (33 kg/m2 versus 30 kg/m2,
p < .0001). A higher proportion of women were also
hypertensive (64 % versus 60 %), had type 2 diabetes (19 %
versus 16 %) and had higher mean HDL cholesterol
(55 mg/dL versus 46 mg/dL), HOMA-IR (3.7 versus 3.4),
CRP (.60 mg/dL versus .37 mg/dL), and plasma adiponec-
tin (6.0 ug/mL versus 4.1 ug/mL) when compared to men
(p = .009, .003, <.0001, <.0001, <.0001, <.0001, respect-
ively). Men had higher mean systolic and diastolic blood
pressure (127.9 mmHg, 81.4 mmHg versus 126.2 mmHg,
77.2 mmHg), LDL cholesterol (128.7 mg/dL versus
125.5 mg/dL), and triglyceride (114.1 mg/dL versus
100.3 mg/dL) (p = .004, <.0001, .006, <.0001, respectively).
There was a significant differential pattern of mean
age and health behavior and health status according to
annual income among men and women as revealed in
Table 2. Men with an annual income of ≤ $19,000 were
significantly older (57 years) than men in the other
income categories (p < .0001). A higher percentage of
men were also current smokers (27 %). Hypertension,
systolic blood pressure, HDL cholesterol, and CRP were
also significantly higher among this group of men
(p = <.0002, .0012, .0006, .003, respectively). On the
other hand, physical activity, alcohol consumption,
BMI, diastolic blood pressure, and LDL cholesterol was
significantly higher among men in the highest annual
income category of ≥ $50,000 when compared to those
in the other income groups (p = <.0001, .0003, .02,
.0003, .0003, .001, respectively). Type 2 diabetes, and
triglyceride were higher among those with an income
of $20,000–$49,000 (p = <.0001, .03, respectively). Rela-
tively the same pattern was observed among women.
The exception was that those in the lowest income
group of ≤ $19,000 had significantly higher BMI, type 2
diabetes, and triglyceride when compared to women in
the other income groups (p = <.0001, <.0001, .003, re-
spectively). Educational level with mean age and health
behavior and health status patterned similarly among
men and women as indicated in Table 3.
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Figure 1 illustrates mean age adjusted adiponectin was
significantly different among men by annual household
income with those in the lowest category having higher
adiponectin (p < .0001). There was no difference among
women. Mean adiponectin was also significantly differ-
ent among men and women based on level of education
with those with < high school level of education having
higher adiponectin (p < .0001, .007, respectively).
Table 4 reveals men with a lower annual income of ≤
$19,999 had significantly higher plasma adiponectin
when compared to men with a higher income of ≥
$50,000. This was evident in the crude model (β (se)
= .26 (.04); p < .0001) and persisted in the fully adjusted
model (β (se) = .16 (.05); p = .0008). The reduction in
model coefficients ranged from 19 to 38 %. Those with a
medium annual income of $20,000–$49,000 had margin-
ally higher plasma adiponectin than men with a higher
annual income of ≥ $50,000. Men with < high school
level of education had significantly higher adiponectin in
the crude model (β (se).25 (.05); p < .0001) and remained
significant when adjusted for age (β (se) .14 (.05); p
= .005), but significance disappeared after adjustment for
health behavior and health status; the coefficients be-
tween both models were reduced by 44 %. There was no
association among men with high school or GED level
of education or among those with some college or voca-
tional training.
There was no significant association between annual
household income and plasma adiponectin observed
among women in any of the models. In the crude model,
women with some college or vocational training had
significantly lower levels of adiponectin than women
with ≥ college level of education (β (se) .09 (03), p = .004).
When adjusted for age, women with < high school level of
education and those with some college or vocational train-
ing had significantly lower plasma adiponectin than
women with ≥ college level (β (se)−.08 (.04), p = .03,−.06
(.03), p = .04, respectively). A 33 % reduction in coeffi-
cients between crude and age adjusted models was ob-
served among those with some college or vocational
training. There was no association in the models adjusted
for health behavior or health status.
Table 5 presents the trends of log-transformed expo-
nentiated level of adiponectin for income and level of
education for each sub-group compared with the highest
sub-group. The results show that men with an annual
household income of ≤ $19,999 and $20,000–$49,000
had significantly higher mean adiponectin than those
with an income of ≥ $50,000 (3.91 and 3.25 versus 3.02,
p < .0001) in the crude unadjusted model. This pattern
persisted in each of the subsequently adjusted models.
There were no differences observed among women by
level of income in the crude, age, health behavior,
and health status adjusted models. In the crude
model, men who had an education level of < high
school and those with high school or GED, had
higher levels of mean adiponectin than men with ≥ college
level of education (3.98, 3.26 versus 3.10, p < .0001). A
similar pattern was observed in the age-adjusted










≤ $19,999 20.95 33.77 –
$20,000–$49,999 33.29 38.49 –
≥$50,000 45.76 27.74 <.0001
Educational level, %
<high school 18.02 16.63 –
High school or GED 18.70 19.63 –
Some college or vocational 29.61 29.82 –
≥College graduate 33.67 33.92 .65
Health Behavior
Current smoker,% 17.75 10.92 <.0001
Physical activity score,
mean ± std.
8.71 ± 2.61 8.27 ± 2.57 <.0001
Alcohol consumption, % 60.24 39.80 <.0001
BMI(kg/m2), mean ± std. 29.84 ± 6.22 32.92 ± 7.63 <.0001
Health Status
Hypertension,% 59.86 63.84 .009
Systolic blood pressure
(mmHg), mean ± std.
127.9 ± 17.82 126.2 ± 18.42 .004
Diastolic blood pressure
(mmHg), mean ± std.
81.45 ± 10.54 77.26 ± 10.12 <.0001
Type 2 diabetes,% 15.57 19.15 .003
LDL cholesterol
(mg/dL), mean ± std.
128.7 ± 36.51 125.5 ± 36.21 .006
HDL cholesterol
(mg/dL), mean ± std.
45.96 ± 12.45 55.19 ± 14.61 <.0001
Triglyceride level
(mg/dL), mean ± std.
114.1 ± 90.22 100.3 ± 60.35 <.0001
HOMA-IR, mean ± std. 3.43 ± 2.39 3.78 ± 2.44 <.0001
C-reactive protein
(mg/dL), mean ± std.
.37 ± 1.04 .60 ± 0.84 <.0001
Plasma adiponectin
(ug/mL), mean ± std.
4.15 ± 3.36 6.09 ± 4.56 <.0001
Abbreviations: std standard deviation, GED graduate equivalency diploma, BMI
body mass index, LDL low-density lipoprotein, HDL high-density lipoprotein,
HOMA-IR homoeostasis model assessment-insulin resistance
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model (p = .006). But differences by education level
were attenuated in the models adjusted for health be-
havior and health status. Women with an education
of < high school, high school or GED, and those with
some college or vocational training had lower levels
of adiponectin than women with ≥ college level of
education (4.74, 4.88, 4.84 versus 5.15; p ≤ .05) after
adjustment for age. This significance, however,
disappeared in the fully adjusted model.
Discussion
Consistent observations of SES gradients in health out-
comes has led to the search for pathways through which
social status may impact health-including biological
mechanisms through which social characteristics and
Table 2 Characteristics among men and women stratified by annual household income (N = 4340)
Annual household income
≤$19,999 $20,000–$49,999 ≥$50,000 P-value
Men (n = 1604)
Age (years), mean ± std 57.56 ± 15.25 54.25 ± 13.09 51.87 ± 11.33 <.0001
Health Behavior
Current smoker, % 27.16 18.64 12.77 <.0001
Physical activity score, mean ± std 7.51 ± 2.77 8.64 ± 2.54 9.30 ± 2.39 <.0001
Alcohol consumption, % 52.99 57.97 65.21 .0003
BMI (kg/m2), mean ± std 29.05 ± 6.97 29.93 ± 6.33 30.13 ± 5.75 .02
Health Status
Hypertension, % 67.37 62.36 54.61 .0002
SBP (mmHg), mean ± std 129.87 ± 20.61 129.00 ± 17.72 126.13 ± 16.32 .0012
DBP(mmHg), mean ± std 79.42 ± 10.88 81.68 ± 10.89 82.20 ± 10.02 .0003
Type 2 diabetes, % 18.90 20.95 10.12 <.0001
LDL cholesterol (mg/dL), mean ± std 122.67 ± 37.74 128.51 ± 38.93 131.59 ± 33.83 .001
HDL cholesterol (mg/dL), mean ± std 48.32 ± 14.46 45.79 ± 12.27 45.05 ± 11.48 .0006
Triglyceride (mg/dl), mean ± std 107.90 ± 68.29 117.06 ± 75.47 114.69 ± 106.62 .03
HOMA-IR, mean ± std 3.16 ± 2.03 3.53 ± 3.02 3.49 ± 2.03 .10
CRP (mg/dL), mean ± std 0.52 ± 1.95 0.39 ± 0.67 0.29 ± 0.52 .003
Women (n = 2736)
Age (years), mean ± std 58.67 ± 14.01 54.25 ± 11.91 51.80 ± 10.61 <.0001
Health Behavior
Current smoker, % 15.25 10.21 6.62 <.0001
Physical activity score, mean ± std 7.59 ± 2.69 8.31 ± 2.51 9.04 ± 2.25 <.0001
Alcohol consumption, % 31.33 37.12 53.76 <.0001
BMI (kg/m2), mean ± std 33.49 ± 8.30 33.13 ± 7.58 31.92 ± 6.71 <.0001
Health Status
Hypertension, % 72.19 64.11 53.26 <.0001
SBP (mmHg), mean ± std 129.88 ± 20.03 125.78 ± 17.82 122.46 ± 16.26 <.0001
DBP(mmHg) 76.83 ± 10.72 77.69 ± 10.08 77.19 ± 9.39 .16
Type 2 diabetes, % 25.88 17.37 13.47 <.0001
LDL cholesterol (mg/dL), mean ± std 126.47 ± 37.80 126.03 ± 35.89 123.69 ± 34.72 .26
HDL cholesterol (mg/dL), mean ± std 55.19 ± 15.19 55.32 ± 14.62 55.00 ± 13.93 .90
Triglyceride (mg/dl), mean ± std 105.42 ± 65.37 99.85 ± 58.84 95.12 ± 55.81 .003
HOMA-IR, mean ± std 3.87 ± 2.28 3.84 ± 2.60 3.63 ± 2.40 .14
CRP (mg/dL), mean ± std 0.64 ± 0.95 0.60 ± 0.79 0.53 ± 0.75 .02
Abbreviations: std standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL high-density
lipoprotein, HOMA-IR homoeostasis model assessment-insulin resistance, CRP C-reactive protein
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experiences may affect functioning and disease out-
comes. One biological pathway that is gaining increasing
interest is subclinical inflammatory processes that are
thought to be involved in both the development and
progression of a number of diseases, including cardiovas-
cular, for which there are known SES gradients [5–10].
Adiponectin is an anti-inflammatory biomarker linked to
CVD [12]. A low concentration of circulating adiponectin
has been associated with a higher risk of CVD and its re-
lated risk factors, including hypertension, type 2 diabetes
and obesity [12, 13, 26]. In addition, these outcomes are
strongly patterned by SES [4]. African Americans have
lower levels of adiponectin, higher prevalence of hyperten-
sion, type 2 diabetes, obesity, and lower SES is dispropor-
tionately prevalent in this population when compared to
other racial/ethnic groups [15, 16]. The purpose of our
Table 3 Characteristics among men and women stratified by education (N = 4340)
Education
< high school High school or GED Some college or vocational ≥ College graduate P-value
Men (n = 1604)
Age (years), mean ± std 65.05 ± 10.64 53.34 ± 12.73 48.92 ± 11.93 52.49 ± 11.67 <.0001
Health Behavior
Current smoker,% 22.22 20.40 21.70 10.43 <.0001
Physical activity score, mean ± std 6.99 ± 2.46 8.38 ± 2.59 9.41 ± 2.52 9.18 ± 2.34 <.0001
Alcohol consumption, % 46.15 58.67 64.48 64.87 <.0001
BMI (kg/m2), mean ± std 28.57 ± 5.70 29.34 ± 5.58 30.60 ± 6.77 30.11 ± 6.21 <.0001
Health Status
Hypertension, % 76.22 60.54 53.32 56.45 <.0001
SBP (mmHg), mean ± std 132.87 ± 20.89 128.47 ± 17.47 126.20 ± 16.96 126.26 ± 16.78 <.0001
DBP(mmHg), mean ± std 79.10 ± 10.76 81.50 ± 10.37 82.57 ± 11.01 81.69 ± 9.93 0.0002
Type 2 diabetes, % 24.03 16.89 13.33 12.26 <.0001
LDL cholesterol (mg/dL), mean ± std 126.54 ± 38.75 126.98 ± 36.27 129.01 ± 35.87 130.56 ± 36.05 0.4188
HDL cholesterol (mg/dL), mean ± std 48.34 ± 13.90 46.04 ± 11.86 45.51 ± 12.43 45.13 ± 11.91 0.0068
Triglyceride (mg/dl), mean ± std 109.24 ± 68.53 108.55 ± 62.68 123.60 ± 95.59 111.13 ± 105.56 0.0643
HOMA-IR, mean ± std 3.15 ± 1.89 3.42 ± 2.27 3.52 ± 2.00 3.51 ± 2.89 0.2609
CRP (mg/dL), mean ± std 0.59 ± 2.11 0.36 ± 0.62 0.32 ± 0.49 0.31 ± 0.60 0.0013
Women (n = 2736)
Age (years), mean ± std 64.97 ± 10.11 57.11 ± 12.26 50.32 ± 11.97 53.20 ± 11.56 <.0001
Health Behavior
Current smoker, % 13.00 11.63 12.95 7.69 0.0014
Physical activity score, mean ± std 6.69 ± 2.42 7.83 ± 2.60 8.71 ± 2.48 8.89 ± 2.33 <.0001
Alcohol consumption, % 20.13 33.90 44.35 48.86 <.0001
BMI (kg/m2), mean ± std 33.42 ± 7.75 33.06 ± 7.44 33.66 ± 8.21 31.93 ± 7.04 <.0001
Health Status
Hypertension, % 82.52 69.81 57.76 56.55 <.0001
SBP (mmHg), mean ± std 132.34 ± 19.42 128.55 ± 20.03 124.12 ± 17.44 123.80 ± 16.92 <.0001
DBP(mmHg), mean ± std 75.21 ± 10.05 77.89 ± 10.27 78.00 ± 10.15 77.24 ± 9.92 <.0001
Type 2 diabetes, % 31.01 18.49 16.89 15.75 <.0001
LDL cholesterol (mg/dL), mean ± std 128.75 ± 37.36 127.76 ± 36.95 125.11 ± 37.74 123.06 ± 33.63 0.0259
HDL cholesterol (mg/dL), mean ± std 56.38 ± 16.02 55.70 ± 14.86 53.59 ± 13.28 55.74 ± 14.81 0.0084
Triglyceride (mg/dl), mean ± std 105.28 ± 54.41 98.73 ± 48.31 103.63 ± 67.07 96.02 ± 62.63 0.0196
HOMA-IR, mean ± std 4.08 ± 2.56 3.89 ± 2.50 3.84 ± 2.30 3.57 ± 2.48 0.0104
CRP (mg/dL), mean ± std 0.67 ± 1.04 0.58 ± 0.79 0.64 ± 0.85 0.53 ± 0.74 0.0104
Abbreviations: std standard deviation, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL
high-density lipoprotein, HOMA-IR homoeostasis model assessment-insulin resistance, CRP C-reactive protein
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study was to investigate the relationship of SES, based on
annual household income and level of education, on level
of adiponectin among African American men and women.
Unlike the association between SES and other novel bio-
markers [5–10], our findings revealed lower SES African
American men had higher protective levels of adiponectin
when compared to higher SES men. For example, African
American men with the lowest household income had
higher levels of adiponectin than those with the highest
household income. Adjusting for health behavior and
health status attenuated the association, but remained a
strong statistical significance. The relationship regarding
adiponectin and level of education was only significant in
the crude and age adjusted models resulting in a mediat-
ing effect with health behavior and health status. There
was no association between annual household income and
differential levels of adiponectin among women. However,
consistent with other studies assessing SES and bio-
markers [5–9], women in our study with lower levels of
education also had lower adiponectin levels compared to
women with ≥ college level of education. However, this re-
lationship disappeared after adjustments for health behav-
ior and health status.
To our knowledge, there are only three publications
that investigated the relationship between SES and adi-
ponectin. Khanolkar, Vagero and Koupil investigated the
association of occupational class and educational level
among a sample of Swedish men 50 to 70 years of age
[10]. They found no association between these SES mea-
sures and adiponectin levels. Researchers in South Africa
investigated the association of adipokine levels and edu-
cational level between African and Asian-Indian women
Fig. 1 Mean age adjusted level of adiponectin for men and women by annual household income and level of education. P value represents
differences in the level of adiponectin for income and education categories based on one-way ANOVA
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[18]. They also report no differential association between
educational level and this adipokine. Buchan et al. report
on the relationship of SES and adiponectin among a
sample of adolescent boys and girls in Scotland [17].
Their findings revealed boys and girls from a lower SES
had significantly lower adiponectin than those from a
higher SES. This finding is consistent with our observation
concerning women. Our findings concerning men, on the
other hand, is contrary with the findings of Buchan et al.
and other investigators assessing the relationship between
SES and other novel biomarkers [5–10, 27]. These investi-
gations revealed deleterious biomarker levels among the
lower SES group. This was particularly evident re-
garding the association of annual household income.
Our findings concerning the association of income
and level of education among men may be due to how
SES indices differentially affect health through inflamma-
tory and anti-inflammatory biomarkers. Several studies
have found that income and education are independently
associated with health [28, 29], only one study has exam-
ined their shared or independent associations with a bio-
marker [30]. Results showed lower education predicted
higher CRP levels independent of income in a sample of
patients with heart disease [31]. However, racial differ-
ences were not reported. In African Americans, it may be
that social position based on income among men affects
health differently than educational status. Proximate fac-
tors associated with income may indeed be a stronger pre-
dictor of adiponectin than more distal factors related to
education. Indeed, men in the lowest income category in
our study had significantly higher protective levels of adi-
ponectin than men in the highest income category after
adjustments for health behavior and health status; BMI
was also lower in this group but higher among men in the
highest income category (Table 2). These findings suggest
that higher income men may have an economic advantage
Table 4 Regression coefficients with standard error of log transformed adiponectin by socioeconomic status for men and women
(N = 4340)
Adiponectin
Men (n = 1604)
aModel 1 bModel 2 cModel 3 dModel 4
Socioeconomic status β (se) P-value β (se) P-value % Red β (se) P-value % Red β (se) P-value % Red
Income
≤ $19,999 .26(.04) <.0001 .21(.04) <.0001 19 % .15(.05) .0012 42 % .16(.05) .0008 38 %
$20,000 - $49,999 .07(0.04) .056 .05(.04) .17 .03(.04) .43 .04(.04) .25
≥$50,000 (referent) –
Education
<high school .25(.05) <.0001 .14(.05) .005 44 % .10(.05) .06 .08(.06) .16
High school or GED .05(.05) .29 .04(.05) .36 .01(.05) .87 .03(.05) .55
Some college or vocational –.009(.04) .83 .02(.04) .60 .01(.04) .73 .001(004) .96
≥College graduate (referent) –
Women (n = 2736)
Income
≤ $19,999 .02(.03) .53 −.04(.03) .20 −.03(.03) .38 −.01(.03) .73
$20,000–$49,999 0.01(0.03) .71 −.01(.03) .73 .008(.03) .79 −.0002(.03) .99
≥$50,000 (referent) –
Education
<high school .02(.04) .52 −.08(.04) .03 −.05(.04) .19 −005(.04) .19
High school or GED −.02(.03) .60 −.05(.03) .12 −.03(.04) .44 −.03(.03) .35
Some college or vocational −.09(.03) .004 −.06(.03) .04 33 % −.03(.03) .31 .01(.03) 0.75
≥College graduate (reference) –
Abbreviations: SE standard error, Red Reduction
Percentage reduction in regression coefficients from Model 1 computed by (regressionModel 1-regression coefficient Models 2, 3, 4)/(regression coefficientModel 1)
aModel 1, unadjusted
bModel 2, adjusted for age
cModel 3, adjusted for age and health behavior (overweight, smoking status, alcohol consumption status, physical activity)
dModel 4, adjusted for age, health behavior and health status (HDL, LDL, triglycerides, hypertension status, type 2 diabetes status, HOMA-IR, CRP)
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and very little barriers to access and exposure to high fat
diet unlike potential economic barriers experienced by
men in the lowest income category.
Strengthens and limitations
The strength of our investigation is that findings were
from the largest community-based sample of African
Americans, a cohort with strict protocol and high quality-
control. It also addresses a risk factor (i.e. adiponectin) as-
sociated with CVD that disproportionately affects African
Americans. In addition, it presents contrary new insight
into historical findings concerning SES gradients and
health-particularly among men. Finally, it is among the
first to report on the association between SES and adipo-
nectin based on a sample population in the United States.
One limitation of the study is that findings cannot be
generalizable to other ethnic groups. Secondly, this is a
cross-sectional analysis; thus, we cannot establish a causal
relationship between SES and adiponectin. Furthermore,
residual confounders may have impacted the results. It is
also important to mention that we use level of education
and annual household income as proxy measures of SES
and not a composite measure of SES. Although we ad-
justed for several known confounders, our study did not
adjust for other factors such as dietary intake, sex hor-
mones, and specific adiposity measures such as visceral
fat. Finally, our study used total adiponectin rather than
high molecular weight (HMW) adiponectin, which is
considered the most biologically active form. This could po-
tentially affect our findings since some studies suggest dif-
ferences in biological activity between different isoforms of
adiponectin and metabolic abnormalities [22]. However,
findings also demonstrate that HMW does not provide
more significant information than total adiponectin [32].
Conclusion
The major finding of our study revealed that, after
adjustments for age, health behavior and health status,
adiponectin was significantly higher in African American
men in the lowest category of income compared to those
in the highest income category. Adiponectin was also
higher among men with the lowest level of education
after adjustment for age. Women with < high school and
some college or vocational level of education had lower
adiponectin than women with the highest level of educa-
tion after age adjustment. Findings suggest a potential
inverse biological pathway associated with annual house-
hold income as a measure of SES and adiponectin in
men. Findings further suggest that perhaps intervention
should be targeted to higher SES African American men
to improve adiponectin level.
Abbreviations
BMI, body mass index; CRP, C-reactive protein; CVD, cardiovascular disease;
GED, graduate equivalency diploma; HDL, high-density lipoprotein; HOMA-IR,
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Study; LDL, low-density lipoprotein; SES, socioeconomic status
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